SEARCH RESULTS FOR: ("Ru-106 Eye Applicator")(111160 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
The OW100S is indicated to provide acoustic pressure shockwave in the treatment of chronic, full-thickness diabetic foot ulcer with wound area measuring no larger than 16 cm2, which extend through the epidermis, dermis, tendon, or capsule, but without bone exposure. The OW100S is indicated for adult (22 year and older), diabetic patients presenting with diabetic foot ulcers greater than 30 days in duration and is indicated for use in conjunction with standard diabetic ulcer care.
The OW100S is indicated to provide acoustic pressure shockwaves in the treatment of superficial partial thickness second degree burns in adults (22 year or older). The OW100S is indicated for use in conjunction with standard of care burn treatment(s).
MTS Medical AG
OW100S-US
In Commercial Distribution
- 04260484571830 ()
- 04260484571823 ()
- Weight: 21 Kilogram
- Depth: 459 Millimeter
- Width: 400 Millimeter
- Height: 218 Millimeter
1000022
- Dermatological extracorporeal shock wave therapy system
The DermaGold100® is intended for treatment of
- diabetic footulcers
- superficial partial thickness second degree burns in adults (22 years and older). The dermagold100 is indicated for use in conjunction with standard of care burn treatment(s)
MTS Medical AG
OW100-US
In Commercial Distribution
- 04260484571649 ()
- 04260484571656 ()
- Weight: 18 Kilogram
- Depth: 459 Millimeter
- Width: 400 Millimeter
- Height: 218 Millimeter
1000014
- Dermatological extracorporeal shock wave therapy system
The OW100S-US is indicated to provide acoustic pressure shockwaves in the treatment of chronic, full-thickness diabetic foot ulcers with wound areas measuring no larger than 16 cm2, which extend through the epidermis, dermis, tendon, or capsule, but without bone exposure. OW100S-US is indicated for adult (22 years and older), diabetic patients presenting with diabetic foot ulcers greater than 30 days in duration and is indicated for use in conjunction with standard diabetic ulcer care.
The OW100S-US is indicated to provide acoustic pressure shockwaves in the treatment of superficial partial thickness second degree burns in adults (22 years or older). The OW100S-US is indicated for use in conjunction with standard of care burn treatment(s)
MTS Medical AG
OW100S-US
In Commercial Distribution
- 04260484571274 ()
- 04260484571267 ()
- Weight: 21 Kilogram
- Depth: 459 Millimeter
- Width: 400 Millimeter
- Height: 218 Millimeter
1000024
- Dermatological extracorporeal shock wave therapy system
Device for ultrasound therapy
Enraf-Nonius B.V.
1631951
In Commercial Distribution
- 08720618311108 ()
- Physical therapy ultrasound system
Device for ultrasound therapy
Enraf-Nonius B.V.
1631940
In Commercial Distribution
- 08720618311221 ()
- Physical therapy ultrasound system
Pretreatment Skin Wipes 8 pack
Zeltiq Aesthetics, Inc.
BRZ-PSW-000-008
In Commercial Distribution
- 10816417020947 ()
- 00816417020940 ()
- Cryolipolysis body contouring system
CoolAdvantage Petite Gasket - 24 Pack
Zeltiq Aesthetics, Inc.
BRZ-LN1-140-024
In Commercial Distribution
- 10816417020916 ()
- 00816417020919 ()
BRZ-LN1-140-024
- Cryolipolysis body contouring system
Gasket, 24-Pack, CoolAdvantage
Zeltiq Aesthetics, Inc.
BRZ-LN2-160-024
In Commercial Distribution
- 10816417020671 ()
BRZ-LN2-160-024
- Cryolipolysis body contouring system
Assembly Pouched Securement Straps, CoolSmooth
Zeltiq Aesthetics, Inc.
BRZ-SS3-09X-012
In Commercial Distribution
- 10816417020565 ()
- 00816417020568 ()
BRZ-SS3-09X-012
- Cryolipolysis body contouring system
CoolSmooth Securement Strap, Short, Qty
Zeltiq Aesthetics, Inc.
BRZ-SS2-09X-012
In Commercial Distribution
- 10816417020558 ()
- 00816417020551 ()
BRZ-SS2-09X-012
- Cryolipolysis body contouring system
Securement System, Qty 12
Zeltiq Aesthetics, Inc.
BRZ-SS1-09X-012
In Commercial Distribution
- 10816417020541 ()
- 00816417020544 ()
BRZ-SS1-09X-012
- Cryolipolysis body contouring system
CoolSmooth Foam Borders
Zeltiq Aesthetics, Inc.
BRZ-FB1-09X-024
In Commercial Distribution
- 10816417020152 ()
- 00816417020155 ()
BRZ-FB1-09X-024
- Cryolipolysis body contouring system
Pretreatment Skin Wipes
Zeltiq Aesthetics, Inc.
BRZ-PSW-000-024
In Commercial Distribution
- 10816417020114 ()
- 00816417020117 ()
BRZ-PSW-000-024
- Cryolipolysis body contouring system
CoolGel Mini Syringe - 24 Syringes In a Carton
Zeltiq Aesthetics, Inc.
BRZ-GS1-000-024
In Commercial Distribution
- 10816417020091 ()
- 00816417020094 ()
BRZ-GS1-000-024
- Cryolipolysis body contouring system
No Description
Zimmer MedizinSysteme GmbH
5345
In Commercial Distribution
- 04053815003311 ()
5345
- Physical therapy ultrasound system
No Description
HILL LABORATORIES CO.
HF54, Horizon
In Commercial Distribution
- 00860001452532 ()
- Physical therapy ultrasound system
Welcome to the Omnisound® 3000 Pro, the system that redefines therapeutic ultrasound. While conceiving and
designing the Omnisound® 3000 Pro, ACP set out to overcome the limitations of ordinary ultrasound devices.
Here are just a few of the functions we developed that make the Omnisound® 3000 Pro truly the future of
ultrasound therapy:
• Controlled Depth of Penetration - The Omnisound® 3000 Pro enables you to treat soft tissue injuries,
superficially with 3 MHz and instantly at the push of a button, treat deeper injuries with 1 MHz - without
switching transducers.
• Two Transducer Sizes - Our 2cm2 and 5cm2 heads offer optimum flexibility in treatment and are automatically
enabled as you change from one to the other.
• Combination Therapy - Interconnect port allows combination therapy with the Omnistim® family of
electrostimulators.
• Excellent BNR and ERA - Our superior BNR and ERA makes for highly uniform and comfortable
applications.
ACCELERATED CARE PLUS CORP
1203000E
In Commercial Distribution
- 10858703006006 ()
- 00858703006009 ()
- Physical therapy ultrasound system
The sustained acoustic medicine, (sam® X1) long-duration ultrasound device is used in the treatment of musculoskeletal injuries and pain relief. sam® X1 is the first wire-free option to deliver continuous wave, high-frequency sustained acoustic medicine (3MHz) into deep tissue resulting in improved circulation and nutrient transfer into the injured soft-tissue for multiple hours each day. This sam® mechanism of action improves and accelerates soft tissue healing for tendinopathies, meniscus injuries, osteoarthritis, joint injuries (knee, shoulder, elbow, wrist) and tissue compromised by repetitive and/or overuse injuries. For pain management secondary to injury, sam® X1 provides localized, non-systemic pain management and is an appropriate treatment alternative for prescribers seeking to avoid the systemic effects of NSAIDs and opiates. sam® X1 is FDA cleared and indicated for prescription home-use, and easily accommodates self-administered treatment by applying the treatment applicator with a hypoallergenic single use pre-filled coupling patch over the soft-tissue injury and activating the battery-operated power controller for autonomous therapeutic delivery.
ZETROZ SYSTEMS, LLC
SA551
In Commercial Distribution
- 00857599005202 ()
SA551
- Physical therapy ultrasound system
The sustained acoustic medicine, (sam® 2.0) long-duration ultrasound device is intended for the treatment of musculoskeletal injuries and pain relief. sam® 2.0 delivers continuous wave, high-frequency sustained acoustic medicine (3MHz) into deep tissue for up to 4 hours, resulting in improved circulation and nutrient transfer into the injured soft-tissue for multiple hours each day. This sam® mechanism of action improves and accelerates soft tissue healing for tendinopathies, meniscus injuries, osteoarthritis, joint injuries (knee, shoulder, elbow, wrist) and tissue compromised by repetitive and/or overuse injuries. For pain management secondary to injury, sam® 2.0 provides localized, non-systemic pain management and is an appropriate treatment alternative for prescribers seeking to avoid the systemic effects of NSAIDs and opiates. sam® 2.0 is FDA cleared and indicated for prescription home-use, and easily accommodates self-administered treatment by applying the treatment applicator with a hypoallergenic single use pre-filled coupling patch over the soft-tissue injury and activating the battery-operated power controller for autonomous therapeutic delivery.
ZETROZ SYSTEMS, LLC
SA271
In Commercial Distribution
- 00857599005196 ()
- Physical therapy ultrasound system
wearable therapeutic ultrasound
ZETROZ SYSTEMS, LLC
sam-12
In Commercial Distribution
- 00857599005073 ()
- Physical therapy ultrasound system